PharmaResearch Co., Ltd. (KOSDAQ:214450)
266,000
+7,500 (2.90%)
Nov 17, 2026, 9:35 AM KST
PharmaResearch Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, PharmaResearch stock has a consensus rating of "Strong Buy" and an average price target of ₩427,733. The average 1-year stock price forecast is 60.80% higher than the current stock price, while the lowest is ₩324,000 (+21.80%) and the highest is ₩530,000 (+99.25%).
Price Target: ₩427,733 (+60.80%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PharmaResearch stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 9 | 9 | 9 | 9 |
| Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 15 | 15 |
Financial Forecast
Revenue This Year
677.40B
from 536.29B
Increased by 26.31%
Revenue Next Year
816.46B
from 677.40B
Increased by 20.53%
EPS This Year
16.64K
from 14.93K
Increased by 11.45%
EPS Next Year
21.41K
from 16.64K
Increased by 28.66%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.